Several other equities research analysts have also weighed in on the stock. JPMorgan Chase & Co. set a €68.90 ($72.53) target price on shares of Gerresheimer in a report on Wednesday, April 13th. Deutsche Bank Aktiengesellschaft set a €115.00 ($121.05) target price on Gerresheimer in a report on Friday, February 18th. Deutsche Bank Rese… set a €115.00 ($121.05) price target on Gerresheimer in a research report on Friday, April 8th. Credit Suisse Group set a €86.00 ($90.53) price objective on Gerresheimer in a research report on Tuesday, April 19th. Finally, The Goldman Sachs Group set a €110.00 ($115.79) target price on shares of Gerresheimer in a report on Thursday, April 7th.
Gerresheimer stock opened at €69.00 ($72.63) on Wednesday. The firm has a market capitalization of $2.17 billion and a price-to-earnings ratio of 25.03. The company’s 50 day simple moving average is €66.57 and its 200 day simple moving average is €74.26. The company has a debt-to-equity ratio of 112.42, a current ratio of 0.75 and a quick ratio of 0.37. Gerresheimer has a fifty-two week low of €53.45 ($56.26) and a fifty-two week high of €99.40 ($104.63).
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements.
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
- Carvana Insiders Buy Shares But Maybe You Shouldn’t
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.